Personalized and targeted mutational analysis of multiple second primary melanomas under kinase inhibitors.
Donati M, Zelano G, Coppola R, Cinelli E, Verri M, Persichetti P, Perrella E, Devirgiliis V, Calvieri S, Crescenzi A, Panasiti V.
Donati M, et al.
Ital J Dermatol Venerol. 2021 Oct;156(5):593-598. doi: 10.23736/S2784-8671.19.06516-7. Epub 2019 Dec 4.
Ital J Dermatol Venerol. 2021.
PMID: 31804055
BACKGROUND: Second primary melanomas (SPMs) are new developed primary melanomas occurring in a subset of patients affected by BRAF-mutated metastatic melanoma during treatment with BRAF-inhibitors. ...We observed that mutations detected in tumor sample …
BACKGROUND: Second primary melanomas (SPMs) are new developed primary melanomas occurring in a subset of patients affected by …